Next Article in Journal
Antifungal Drugs for the Treatment of Invasive Fungal Infections—A Limited Therapeutic Toolbox Facing Growing Resistances
Previous Article in Journal
Correction: Wang et al. Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals 2023, 16, 1000
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119

1
Department of Pharmaceutical Chemistry, College of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Trinity Biomedical Sciences Institute, 152-160 Pearse Street, Dublin 2, DO2R590 Dublin, Ireland
3
Molecular Design Group, School of Biochemistry and Immunology, Trinity College Dublin, Trinity Biomedical Sciences Institute, 152-160 Pearse Street, Dublin 2, DO2R590 Dublin, Ireland
4
School of Biochemistry and Immunology, Trinity College Dublin, Trinity Biomedical Sciences Institute, 152-160 Pearse Street, Dublin 2, DO2R590 Dublin, Ireland
5
School of Chemistry, Trinity College Dublin, Dublin 2, DO2R590 Dublin, Ireland
*
Author to whom correspondence should be addressed.
Co-First Authors: contributed equally to the work.
Pharmaceuticals 2025, 18(8), 1219; https://doi.org/10.3390/ph18081219
Submission received: 29 July 2025 / Revised: 31 July 2025 / Accepted: 7 August 2025 / Published: 19 August 2025
(This article belongs to the Section Medicinal Chemistry)

Error in Figure and Legend

In the original publication [1], there was a mistake in Figure 8 as published. The corrected Figure 8 and Legend appears below.

Text Correction

There was an error in the original publication [1]. A correction has been made to Section 3.3.8. Immunofluorescence Assay:
Confocal microscopy was used to study the effects on MCF-7 cytoskeleton following treatment with compound 10n following the protocols previously reported [34]. For each experiment, all images were collected on the same day using identical parameters. MCF-7 cells were seeded (1 × 105 cells/mL) on eight chamber glass slides. Cells were either untreated or treated with vehicle (1% ethanol (v/v)), CA-4 (10 nM), Paclitaxel (1 μM) and β-lactam compound 10n at 50 nM, 100 nM and 500 nM concentrations for 16 h. The cells were then gently washed in PBS and then fixed for 30 min with 100% ice-cold MeOH. Cells were washed three times in PBS for 10 min and then permeabilised in 0.5% Triton X-100. The cells were subsequently washed in PBS containing 0.1% Tween (PBST), and then blocked in bovine serum albumin (5%) diluted in PBST. Cells were then incubated with a mouse monoclonal anti-α-tubulin−FITC antibody (clone DM1A) (1:200) for 2 h at 20 °C. Following washes in PBST, cells were incubated with Alexa Fluor 488 dye (1:500) for 1 h at 20 °C. Following further washes in PBST, the cells were mounted in Ultra Cruz Mounting Media, which contained 4,6-diamino-2-phenolindol dihydrochloride (DAPI). The images were photographed using Leica SP8 confocal microscopy with the Leica application suite X software program. Experiments were performed on three independent occasions.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Malebari, A.M.; Wang, S.; Greene, T.F.; O’Boyle, N.M.; Fayne, D.; Khan, M.F.; Nathwani, S.M.; Twamley, B.; McCabe, T.; Zisterer, D.M.; et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119. [Google Scholar] [CrossRef] [PubMed]
Figure 8. Compound 10n depolymerises the microtubule network of MCF-7 breast cancer cells. Cells were treated with (A) vehicle control (0.1% ethanol (v/v)), (B) CA-4 (10 nM), (C) paclitaxel (1 μM) and compound 10n, (D) (50 nM), (E) (100 nM) and (F) (500 nM) for 16 h. Cells were fixed in ice-cold methanol and stained with mouse monoclonal anti-α-tubulin–FITC antibody (clone DM1A) (green) and Alexa Fluor 488 dye, and counterstained with DAPI (blue). Images were obtained with Leica SP8 confocal microscopy with Leica application suite X software. Representative confocal micrographs of three separate experiments are shown. Scale bar indicates 25 μm.
Figure 8. Compound 10n depolymerises the microtubule network of MCF-7 breast cancer cells. Cells were treated with (A) vehicle control (0.1% ethanol (v/v)), (B) CA-4 (10 nM), (C) paclitaxel (1 μM) and compound 10n, (D) (50 nM), (E) (100 nM) and (F) (500 nM) for 16 h. Cells were fixed in ice-cold methanol and stained with mouse monoclonal anti-α-tubulin–FITC antibody (clone DM1A) (green) and Alexa Fluor 488 dye, and counterstained with DAPI (blue). Images were obtained with Leica SP8 confocal microscopy with Leica application suite X software. Representative confocal micrographs of three separate experiments are shown. Scale bar indicates 25 μm.
Pharmaceuticals 18 01219 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Malebari, A.M.; Wang, S.; Greene, T.F.; O’Boyle, N.M.; Fayne, D.; Khan, M.F.; Nathwani, S.M.; Twamley, B.; McCabe, T.; Zisterer, D.M.; et al. Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119. Pharmaceuticals 2025, 18, 1219. https://doi.org/10.3390/ph18081219

AMA Style

Malebari AM, Wang S, Greene TF, O’Boyle NM, Fayne D, Khan MF, Nathwani SM, Twamley B, McCabe T, Zisterer DM, et al. Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119. Pharmaceuticals. 2025; 18(8):1219. https://doi.org/10.3390/ph18081219

Chicago/Turabian Style

Malebari, Azizah M., Shu Wang, Thomas F. Greene, Niamh M. O’Boyle, Darren Fayne, Mohemmed Faraz Khan, Seema M. Nathwani, Brendan Twamley, Thomas McCabe, Daniela M. Zisterer, and et al. 2025. "Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119" Pharmaceuticals 18, no. 8: 1219. https://doi.org/10.3390/ph18081219

APA Style

Malebari, A. M., Wang, S., Greene, T. F., O’Boyle, N. M., Fayne, D., Khan, M. F., Nathwani, S. M., Twamley, B., McCabe, T., Zisterer, D. M., & Meegan, M. J. (2025). Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119. Pharmaceuticals, 18(8), 1219. https://doi.org/10.3390/ph18081219

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop